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THE occurrence of fever in neoplastic disease is a well-recognised phenomenon
but its significance is frequently difficult to assess. The associated cachexia
predisposes to infection and the fever is often explained on this basis. There are
however certain neoplasms with which a distinctive pattern of fever may occur
without evidence of infection. Examples of these are the classical Pel-Ebstein
fever of Hodgkin's disease and the fever not infrequently associated with renal
carcinoma and uterine myosarcoma. The pathogenesis of the febrile response in
these diseases is unknown but the failure to detect infection has favoured an
interpretation based on tissue necrosis. The use of antibiotics in these patients
has strengthened this view. In a controlled series of patients Boggs, Frei and
Zierdt (1960) have studied the effect of tetracycline therapy on fever associated
with neoplasia and found that it had no effect and it is frequently observed that
though the fever fails to respond to antibiotic therapy, rapid defervescence may
occur with the use of cortisone. Moreover, with the use of cytotoxic drugs in
these patients it is often found that the temperature rises shortly after the onset of
therapy and fever persists while the cytotoxic agent is used. Experience in man,
therefore, gained by clinical observation and by the use ofantibiotic and cytotoxic
drugs indicates that tumour necrosis may be important in the pathogenesis of the
fever ofneoplasia. As a preliminary experimental investigation ofthis hypothesis
the temperature of rats, into which a spontaneously-necrosing tumour has been
transplanted, has been studied and attempts made to identify a pyrogenic principle
in the tumour.
MIATERIALS AND METHODS
Experimental animals. Adult male Norway rats were used. The animals
were divided into groups. Those in Group A acted as hosts for the tumour;
those in Group B acted as controls and at a later date were recipients for injection
of extracts of the tumour. Both groups were fed on Thomson Cube No. 1 diet
and were kept in individual cages in a well-aired room maintained at a constant
temperature of 22° C.
Tumour. WTalker carcinoma was used. This tumour necroses spontaneously
approximately 10 days after implantatioin.
Transplantation technique.-A strict aseptic technique was used which included
the wearing ofmasks and of sterile gloves. Donors were anaesthetised with ether,
the skin over the tumour was shaved and cleaned with " Savlon " and iodine, a
portion of tumour was removed through a 5 cm. long incision and was placed in a
sterile glass container encased in ice. The excised tumour was then mincedFEVER AND TUMOUR NECROSIS
using fine instruments, and small portions were injected into the subcutaneous
tissues of the new host using a wide bore needle and syringe. Some ofthe control
animals were injected subcutaneously with sterile saline. Sterilisation of glass-
ware, needles, etc. was by dry heat for 2 hours at 170° C. Sterile solutions (for
example saline and Hank's solution) were tested in normal animals to ensure
apyrogenicity.
Assessment of transplantation success.-Usually within 4 days oftransplantation
the growing transplanted tumour was apparent in the new host. Several animals
were killed at 7, 10 and 21 days after transplantation and sections of tumour were
taken for histological examination and were stained with haematoxylin and eosin
and Brown's stain.
Preparation of turnour extracts. Apparently-viable and obviously-necrotic
portions of tumour were excised and placed in approximately 5 gram quantities
in four times their volume of one of two solutions (a) sterile 0 9 per cent saline to
which penicillin and streptomycin had been added in a concentration of 500 units
of penicillin and 500 /ig. of streptomycin per ml. of fluid, (b) Hank's solution,
containing penicillin and streptomycin in the above-stated concentrations. The
tumour was minced and mechanically homogenised and the resultant mixture was
divided into approximately 10 ml. quantities. After washing by centrifugation,
these were incubated at 370 C. for periods varying from 12 to 24 hours. Centrifu-
gation was again carried out at 1,000 r.p.m. for 15 minutes at 4° C. and thesuper-
natant fluid was removed and passed through a Seitz filter. All extracts were
stored at 40 C. and were used within 3 days ofpreparation after testing for sterility
by aerobic and anaerobic culture.
Injection of tumour extracts. Extracts of tumour prepared in saline and in
Hank's solution were injected, using aseptic technique, in 5 ml. quantities by
intraperitoneal injection in the two groups of animals. Group A were hosts in
which tumour had been growing for 14 to 21 days while Group B were normal
animals. In some of Group B extracts were injected on two successive days.
Temperature readings. (a) Temperature was recorded daily at 12 noon and at
4.00 p.m. in host animals and in controls. A centigrade thermometer was used
(sensitive to 0.10 C.). The instrument was inserted rectally and was left inpositioln
for 3 minutes before each reading. (b) Recipients of tumour extract had their
temperature recorded rectally at 60 and at 30 minutes before injection of extract.
Those animals showing a variation greater than 0*5° C. were discarded. Tempera-
ture was recorded at 30 minute intervals for 5 hours after injection.
Assessment offebrile response. Temperature readings were recorded in degrees
centigrade and were plotted as degrees offever against time. In those experiments
where daily readings were recorded the highest value for the day was used. The
mean febrile responses of the various experimental groups were plotted and mean
maximum responses and areas under the temperature curves (measured by
planimetry and recorded as degrees centrigrade-time) were used for comparison
of the experimental groups.
Criticissm of experimental methods. The use of the rat as an experimental
animal for production of fever might be criticised on the grounds that its response
to bacterial endotoxin is unpredictable (Atkins, 1960). The mechanism of fever
in neoplasia is, however, unknown and may not be related to that of endotoxin
fever. Although Bolognari (1959) has described nucleolar granules in Walker
carcinoma, their significance is uncertain and repeated experiment has failed to
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reveal the presence of a virus. It was thought therefore that this would be a
suitable tumour for experimental fever with the advantage of inevitable necrosis
outweighing the possible disadvantage of poor febrile response. The tumour
was not examined histologically in every animal as fever might occur following the
removal of tissue for biopsy: representative sections were, however, taken from
several animals not used for temperature readings. In all sections of tumour
studied at 7 days or more after transplantation extensive necrosis was found.
RESULTS
Transplantation of tumour
Thirty-nine rats received tumour transplants and, ofthese, in 33 (84-6 per cent)
transplantation was successful. Animals survived for varying periods of time
after transplantation but the majority died within 21 days. Some were killed to
prevent terminal infection with possible effect on temperature. Histological
examination ofthe tumour (Fig. 1) showed it to be an anaplastic round-cell tumour,
growing in sheets and infiltrating surrounding tissues. Extensive necrosis was
invariably found in sections taken 7 or more days after transplantation. Meta-
static deposits were not found. Sections stained by Brown's technique were nega-
tive for micro-organisms.
Daily temperature in controls
The control group comprised 10 adult male rats all of which showed slight
variation in daily temperature (Fig. 2). The mean maximum fever, however,
recorded forthe group over a period of30 days was 0.20 C. (Fig. 3). The area under
the mean fever curve was 2-2° C. days.
Daily temperature in animals with tumour
The majority showed little deviation from the control mean temperature until
the ninth or tenth day after transplantation (Fig. 2 and 3). Thereafter a sharp
rise in temperature usually occurred and some degree of pyrexia persisted until
death. The mean febrile response of the group is shown in Fig. 3. It is apparent
that with the onset oftumour necrosis at the tenth day there is divarication ofthe
mean temperature curves of the control and tumour groups, and on the majority
ofsucceeding days there is a very marked difference in the two groups. The area
under the mean fever curve of the tumour group was 45.00 C. days (as opposed to
2-2 for the control group). Statistical comparison (using the " t " test) ofthe fever
curve areas of animals in the experimental group with those of animals in the
control group shows a highly significant difference: 0*01>P>0-001.
Length of survival after tumour transplantation
The mean fever curve of the animals with carcinoma has a biphasic form and
this persists even when account is taken ofthe early death of some ofthe animals.
EXPLANATION OF PLATE
FIG. 1.-Walker carcinoma in subcutaneous tissues of rat. Extensive necrosis is apparent.
H. and E. x 75.
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Nineteen ofthe 33 animals inthe group (57.5 per cent) died between the nineteenth
and twenty-first day afterimplantation oftumour. Only 8 animals (24.2 per cent)
survived the full 30 days. Fig. 4 is a comparison ofthe mean temperature curves
ofthe 21-day and 30-day survivors. The 30-day survivors show an earlier febrile
response but in both groups the mean curve is biphasic.
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FIG. 2.-Examples of daily temperature chart of normal control rat and of rat with Walker
carcinoma.
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FIG. 3.-Mean daily temperature readings in rats with carcinoma and in normal rats.
Febrile response of rats with carcinoma to injection of tumour extract
Fig. 5 shows the mean febrile response of 12 rats with tumour to intraperitoneal
injection of5 ml. oftumour extracted in Hank's solution. A mean rise in tempera-
ture occurred approximately 60 minutes after injection and the mean maximum
febrile response, occurring at 240 minutes, was 0-6' C. The area under the mean
fever curve was 2-10C.-minutes (area for control Hank's solution 0O4°C.-minutes).
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Febrile response of normal rats to injection of tumour extract
The normal rats also showed arise in temperature within 60 minutes ofinjection
ofextract. The meanmaximumfebrile response was 1-2°C. (occurring 240minutes
after injection-see Fig. 5). The area under the mean fever curve was 4.90 C.-
minutes (control solution 0.40 C.-minutes).
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FiG. 5.-Mean febrile response of normal and of carcinomatous rats to injection of tumour
extract.
Febrile response of normal rats to injection of tumour extract on 2 successive days
Fig. 6 shows the mean febrile response of 12 normal rats to injection of 5 ml. of
tumour extract on 2 successive days. On day 2 a marked increase in the latent
period was noted; a mean rise in temperature did not occur until 120 minutes
after injection (as opposed to 30 minutes on day 1). The mean maximum febrile
response on the 2 days was almost identical (1.-70 C. day ; 1. 80 C. day 2). There
is, however, a decrease in the area under the fever curve on day 2-6-40 0.-minutes
as opposed to 9.20 0.-minutes on day 1. These findings indicate the reduced
febrile response of normal rats on the second day of injection of tumour extract.
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Comparative pyrogenicity of saline and Hank's solution tumour extracts
Fig. 7 shows that although the mean maximum febrile response with Hank's
solution extract was twice that produced by saline extract, the areas under the
two fever curves were, however, comparable: Area for Hank's solution extract-
5.50 C.-minutes. Area for saline extract 4.00 C.-minutes.
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Fica. 6.-Mean febrile response of normal rats to injection of tumour extract on two successive
days.
3 CONTROL SOLUTIONS
Z ---SALINE TUMOUR, EXTRACT
U~~~~~~~~~
u ...........HANKS SOLUTION TUMOUR EXTRACT
V)~~~~~~~~~I
uJ -
U.
- ~ ~ ,
0 60 120 180 240 300
TIME, MINUTES
FIG. 7.- Comparison of the pyrogenicity of tumour extracts prepared in saline and in Hank's
solution.
DISCUSSION OF EXPERIMENTAL FINDONGS
The marked difference in the meandailytemperature ofthe tumour and control
groups from the tenth day onwards would suggest that the onset of fever was
related to necrosis of the neoplasm. Histological examination of the tumour at
this time invariably revealed extensive necrosis with a comparatively slight
inflammatory reaction. This apparent relationship of fever to tumour necrosis
has, of course, its human parallel. It is common for patients with rapidly-
growing and extensively-necrosing neoplasms to develop fever, and various hypo-
theses have been advanced to explain this reaction. In the ensuing discussion the
following pathogenetic possibilities will be considered in the light of the recorded
exrperimental results.
1. Fever occurs as a result of secondary infection of a site other than that of
the primary neoplasm.
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2. Tumour necrosis predisposes to bacterial invasion of the tumour with
consequent infection.
3. Tumour necrosis engenders liberation ofprotein molecules foreign to the host
reticulo-endothelial system. The resultant development ofantibodies is manifest
by the febrile reaction of hypersensitivity.
4. Tumournecrosis is accompanied byliberation oftissue polysaccharides which
may exert a direct or indirect pyrogenic effect without an intermediate antibody
reaction.
The frequent occurrence of infection as a complication of neoplastic cachexia
has resulted in its acceptance as the most feasible explanation of the associated
fever. Many patients, however, develop low grade fever some months before
death without clinical evidence of infection, and the failure of these patients to
respond to any form ofantibiotic therapy would suggest that their fever cannot be
explained on the basis of an infection in a site unrelated to the primary neoplasm
towhichadministered antibioticsshouldhavefree access. Thepossibilityremains,
however, that colonies of bacteria, engulfed by necrotic tumour may escape
destruction no matterhowintensive the antibiotic therapy. Such organisms could
exert a sustained pyrogenic effect by liberation ofendotoxins. Several arguments
canbe usedagainstthis explanation in the case ofthe animalsusedinthisinvestiga-
tion. First, although extensive necrosis was invariably found in all tumours
examined from the tenth day after implantation, the inflammatory reaction in
areas ofnecrosis was slight and unlike that usually found when secondary infection
supervenes. Secondly, the staining of histological sections for micro-organisms
did not reveal their presence and, in addition, all preparations of tumour extract
were cultured but were found to be sterile. For these reasons, it seems unlikely
that survival of bacteria within the tumour is the explanation of the associated
fever, and the alternative theory that the pyrogenic principle is of tumour origin
must be accepted as a strong possibility.
Of the numerous products of tissue breakdown the two groups of substances
most likely to exert a pyrogenic effect are the proteins and the polysaccharides.
If protein is responsible, then the resultant fever could be expected to have the
characteristics associated with hypersensitivity; alternatively, tissue poly-
saccharides, though possibly antigenic, have been shown to have a pyrogenic
effect similar to that of bacterial endotoxins (Landy and Shear, 1957a, b). The
experiments described here on injection of tumour extract in normal animals and
in animals with previously-implanted tumour are significant in an evaluation of
the possible role of protein or of polysaccharide in the associated fever. If the
explanation of this fever is an underlying hypersensitivity to circulating tumour
protein, one might predict that animals in which tumour was already growing
would react in greater degree than would the normal animals. In fact, the mean
febrile responses ofthe neoplastic group was approximately halfthat ofthe normal
group (Fig. 5). This result, however, does not obviate the possibility of a hyper-
sensitive mechanism for this fever. It has been shown that repeated antigenic
challenge in hypersensitive animals may lead to desensitisation with loss offebrile
response (UhrandPappenheimer, 1958). It couldtherefore be arguedthat animals
in which tumour had been already implanted might have been partially-desensi-
tised to the products of tumour necrosis. A strong argument, however, against
a hypersensitive basis for this fever is the finding that normal animals have a
diminished febrile response to injection oftumour extract on the second successive
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day (Fig. 6). This is the converse of what is found when protein is injected into
nornmal aninmals, the sensitising stimulus being provided by the first injection and
the hypersensitive response becoming apparent on later injection. In fact, this
diminished febrile response in normal animals on the second day of injection is
the characteristic response to bacterial endotoxins or to tissue polysaccharides
The methods employed by Landy and Shear (see Shear and Perrault, 1953) for
extraction of polysaccharide fronm tissues are so drastic that it is difficult to
imagine conmparable chemical changes proceeding in vivo. Nevertheless, the work
of Burrows (1958) and of Makari (1958) would support the view that in vivo
liberation of polysaccharide occurs. Burrows suggests that the antigenic activity
ofserum from patients with carcinoma is caused by a polypeptide probably closely
linked to a polysaccharide Makari has emphasised that the antigenic component
ofthis complex is the polysaccharide. It is possible therefore that similar products
of tumour breakdown may exert a pyrogenic effect.
SUMMARY
The temperature of rats after implantation of Walker carcinoma has been
studied and an attempt has been made by macroscopic and histological examination
of the tumour to correlate the onset of fever with tumour necrosis.
Extracts of the tumour have been prepared and their effect on the body tem-
perature of normal animals and of animals with previously implanted tumour has
been observed.
The experimental findings support the hypothesis that tumour necrosis is an
important pathogenetic factor in the fever associated with malignant disease.
The pyrogen is almost certainly endogenous rather than exogenous: its exact
biochemical nature is uncertain but the character of the febrile response to the
tumour extract would suggest that it is polysaccharide rather than protein. Its
relationship to cancer antigens has been discussed and it is possible that it may have
a similar origin to the polysaccharide which Makari believes is the antigenic
stimulus to circulating antibody in patients with carcinoma.
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